The weekly litigation news digest is live. Subscribe now

IP Verse

Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease - EP3678649

The patent EP3678649 was granted to Aegis Therapeutics on Dec 21, 2022. The application was filed on Feb 6, 2019 under application number EP19751807A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3678649

AEGIS THERAPEUTICS
Application Number
EP19751807A
Filing Date
Feb 6, 2019
Status
Granted And Under Opposition
Sep 23, 2022
Publication Date
Dec 21, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
AERAJul 24, 2023BARDEHLE PAGENBERG SLADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONAT386414B
DESCRIPTIONUS2015005356
DESCRIPTIONUS2015374832
DESCRIPTIONUS2017216199
DESCRIPTIONUS5369095
DESCRIPTIONWO2011139838
DESCRIPTIONWO2015095389
INTERNATIONAL-SEARCH-REPORTUS2015005356
INTERNATIONAL-SEARCH-REPORTUS2015374832
OPPOSITIONUS2018169247
SEARCHUS2017216199
SEARCHUS5369095
SEARCHWO2011139838
SEARCHWO2015095389

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents